SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 30.42-1.1%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Trumptown who wrote (52)2/16/1997 10:03:00 PM
From: Gerald Thomas   of 455
 
I think this companies problems can be summed up in one word

PR.. they just haven't figured how to deal with the public...

I was just watching the price with amazement figuring it would deflate
after the conference on no new news... But I think when some
news (earnings) finally came out the market had a reality check....

I think the company first needs to say what the boundaries are for the systemic trial.. and then deal with the topical trial...good or bad
the stock will probably react favorably...

To be honest I thought the price increase might have been due
to the statement" PRO -2000 has been shown to BLOCK infection and seems well suited for this application"

But sooner or later they have to spill the beans on what is happening
with PRO-2000 in the systemic trial and everything else is tied to
that information............
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext